Kerendia may soon be authorized in the EU for heart failure and an ejection fraction of 40% or higher.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/mineralocorticoid-blocker-gets-eu-nod-heart-failure-2026a10003cs?src=rss
Author :
Publish date : 2026-02-03 12:38:00
Copyright for syndicated content belongs to the linked Source.